These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8210542)

  • 1. [The role of cellular kinetics as a predictive index of response to radiotherapy: state of the art and future perspectives].
    Sannazzari GL
    Radiol Med; 1993 Sep; 86(3):322-6. PubMed ID: 8210542
    [No Abstract]   [Full Text] [Related]  

  • 2. Back to the drawing board on immunohistochemistry and predictive factors.
    Henson DE
    J Natl Cancer Inst; 2005 Dec; 97(24):1796-7. PubMed ID: 16368935
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proliferative characteristics of the cells].
    Nakamura S
    Rinsho Byori; 1990 Nov; Suppl 87():111-25. PubMed ID: 2287082
    [No Abstract]   [Full Text] [Related]  

  • 4. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma.
    Oka K; Suzuki Y; Nakano T
    Cancer; 2000 Oct; 89(7):1526-31. PubMed ID: 11013367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and response to chemotherapy and radiotherapy.
    Ruley HE
    Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell proliferation markers in human solid tumors: assessing their impact in clinical oncology.
    Daidone MG; Costa A; Silvestrini R
    Methods Cell Biol; 2001; 64():359-84. PubMed ID: 11070848
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
    Webster L; Hodgkiss RJ; Wilson GD
    Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
    Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F
    Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA content and proliferative activity in children with neuroblastoma.
    Yalçin B; Kutluk T; Kansu E; Göğüş S; Canpinar H; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2000; 17(1):45-54. PubMed ID: 10689714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy.
    Kuropkat C; Rudolph P; Parwaresch R; Werner JA
    Anticancer Res; 2003; 23(5A):3965-70. PubMed ID: 14666704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive tests of radiocurability: towards a custom-made radiotherapy?].
    Cosset JM; Peters LJ; Girinsky T; Guichard M; Eschwege F; Mornex F; Malaise EP
    Bull Cancer Radiother; 1990; 77(2):83-94. PubMed ID: 8703551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protooncogene c-myc amplification and cell cycle analysis in human malignant tumors].
    Kita M; Okawa T; Hasegawa N; Maruyama I; Karasawa K; Kaneyasu Y; Tanaka M
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):834-8. PubMed ID: 8489294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From cellular to high-throughput predictive assays in radiation oncology: challenges and opportunities.
    Bentzen SM
    Semin Radiat Oncol; 2008 Apr; 18(2):75-88. PubMed ID: 18314062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein.
    Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H
    Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nasopharyngeal carcinoma: state of the art and new perspectives (review).
    Sanguineti G; Corvo R
    Oncol Rep; 1999; 6(2):377-91. PubMed ID: 10023009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follicular lymphoma].
    Illés A; Krenács L; Borbényi Z
    Orv Hetil; 2003 Nov; 144(46):2253-61. PubMed ID: 14702920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Oncology Forum: perspectives for the year 2000.
    DeVita VT; Bleickardt EW
    Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
    Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
    Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
    J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.